Press What’s news at AbelsonTaylor Group
Select category
What pharma marketers should know about Bluesky
In the ever-changing world of social media, Bluesky has emerged as an intriguing new platform, particularly for HCPs and the broader pharma industry. As a decentralized, ad-free network, it offers a unique environment compared to other mainstream social platforms. In a featured article in MedAdNews, Helen Hoye, associate director of engagement strategy at AbelsonTaylor Group, shares some key things for pharma marketer to know about Bluesky.
Read more: https://www.pharmalive.com/what-pharma-marketers-should-know-about-bluesky/
Media Contact:
Recent Posts
The missing skill in the AI era isn’t prompting — It’s curiosity
“Curiosity is what builds judgment, and this is why AI is most powerful in the hands of curious people,” according...
In the News Read more The missing skill in the AI era isn’t prompting — It’s curiosityThe biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.
As AI adoption accelerates, trust may be the real differentiator. In MedAdNews, Janet Barker-Evans, Chief Creative Officer of AbelsonTaylor Group,...
In the News Read more The biggest barrier to AI adoption in healthcare isn’t regulation. It’s trust.From Insights to Action: The Bridge Between Strategy and Execution
“Having access to more information doesn’t automatically lead to better decisions—you need judgment,” says AbelsonTaylor Group’s Amy Restko, VP, Engagement...
In the News Read more From Insights to Action: The Bridge Between Strategy and ExecutionConnect with us
Find out what's top of mind for the people reimagining health and wellness advertising.